BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 10028924)

  • 1. Modulation of HERG potassium channels by extracellular magnesium and quinidine.
    Po SS; Wang DW; Yang IC; Johnson JP; Nie L; Bennett PB
    J Cardiovasc Pharmacol; 1999 Feb; 33(2):181-5. PubMed ID: 10028924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of HERG potassium channel current by the class 1a antiarrhythmic agent disopyramide.
    Paul AA; Witchel HJ; Hancox JC
    Biochem Biophys Res Commun; 2001 Feb; 280(5):1243-50. PubMed ID: 11162661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High affinity open channel block by dofetilide of HERG expressed in a human cell line.
    Snyders DJ; Chaudhary A
    Mol Pharmacol; 1996 Jun; 49(6):949-55. PubMed ID: 8649354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of the HERG human cardiac K(+) channel by the antidepressant drug amitriptyline.
    Jo SH; Youm JB; Lee CO; Earm YE; Ho WK
    Br J Pharmacol; 2000 Apr; 129(7):1474-80. PubMed ID: 10742304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of the antimalarial drug mefloquine with the human cardiac potassium channels KvLQT1/minK and HERG.
    Kang J; Chen XL; Wang L; Rampe D
    J Pharmacol Exp Ther; 2001 Oct; 299(1):290-6. PubMed ID: 11561091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.
    Thomas D; Wendt-Nordahl G; Röckl K; Ficker E; Brown AM; Kiehn J
    J Pharmacol Exp Ther; 2001 May; 297(2):753-61. PubMed ID: 11303067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single HERG delayed rectifier K+ channels expressed in Xenopus oocytes.
    Zou A; Curran ME; Keating MT; Sanguinetti MC
    Am J Physiol; 1997 Mar; 272(3 Pt 2):H1309-14. PubMed ID: 9087606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channels.
    Kiehn J; Thomas D; Karle CA; Schöls W; Kübler W
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):212-9. PubMed ID: 10208308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of recombinant HERG K+ channel blockade by the Class Ia antiarrhythmic drug procainamide.
    Ridley JM; Milnes JT; Benest AV; Masters JD; Witchel HJ; Hancox JC
    Biochem Biophys Res Commun; 2003 Jun; 306(2):388-93. PubMed ID: 12804575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase A-mediated phosphorylation of HERG potassium channels in a human cell line.
    Wei Z; Thomas D; Karle CA; Kathöfer S; Schenkel J; Kreye VA; Ficker E; Wible BA; Kiehn J
    Chin Med J (Engl); 2002 May; 115(5):668-76. PubMed ID: 12133532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voltage-dependent profile of human ether-a-go-go-related gene channel block is influenced by a single residue in the S6 transmembrane domain.
    Sănchez-Chapula JA; Ferrer T; Navarro-Polanco RA; Sanguinetti MC
    Mol Pharmacol; 2003 May; 63(5):1051-8. PubMed ID: 12695533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel.
    Sanguinetti MC; Jiang C; Curran ME; Keating MT
    Cell; 1995 Apr; 81(2):299-307. PubMed ID: 7736582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antihistamine fexofenadine does not affect I(Kr) currents in a case report of drug-induced cardiac arrhythmia.
    Scherer CR; Lerche C; Decher N; Dennis AT; Maier P; Ficker E; Busch AE; Wollnik B; Steinmeyer K
    Br J Pharmacol; 2002 Nov; 137(6):892-900. PubMed ID: 12411421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of HERG and Kv1.5 by ketoconazole.
    Dumaine R; Roy ML; Brown AM
    J Pharmacol Exp Ther; 1998 Aug; 286(2):727-35. PubMed ID: 9694927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG.
    Rampe D; Roy ML; Dennis A; Brown AM
    FEBS Lett; 1997 Nov; 417(1):28-32. PubMed ID: 9395068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class III antiarrhythmic drugs block HERG, a human cardiac delayed rectifier K+ channel. Open-channel block by methanesulfonanilides.
    Spector PS; Curran ME; Keating MT; Sanguinetti MC
    Circ Res; 1996 Mar; 78(3):499-503. PubMed ID: 8593709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular determinants of dofetilide block of HERG K+ channels.
    Ficker E; Jarolimek W; Kiehn J; Baumann A; Brown AM
    Circ Res; 1998 Feb; 82(3):386-95. PubMed ID: 9486667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open channel block by KCB-328 [1-(2-amino-4-methanesulfonamidophenoxy)-2-[N-(3,4-dimethoxyphenethyl)-N-methylamino]ethane hydrochloride] of the heterologously expressed human ether-a-go-go-related gene K+ channels.
    Park JB; Choe H; Lee YK; Ha KC; Rhee KS; Ko JK; Joo CU; Chae SW; Kwak YG
    J Pharmacol Exp Ther; 2002 Jul; 302(1):314-9. PubMed ID: 12065732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic modulation of HERG potassium channels by the volatile anesthetic halothane.
    Li J; Correa AM
    Anesthesiology; 2002 Oct; 97(4):921-30. PubMed ID: 12357160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular physiology and pharmacology of HERG. Single-channel currents and block by dofetilide.
    Kiehn J; Lacerda AE; Wible B; Brown AM
    Circulation; 1996 Nov; 94(10):2572-9. PubMed ID: 8921803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.